Fulltext

How Should a Safe and Effective COVID-19 Vaccine be Allocated? Health Economists Need to be Ready to Take the Baton

Roope LSJ 1 , Buckell J 1 , Becker F 1 , Candio P 1 , Violato M 1 , Sindelar JL 2 Show all authors , Barnett A 3 , Duch R 4 , Clarke PM 5

Affiliations 

  • 1 Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK
  • 2 Department of Health Policy and Management, Yale School of Public Health, New Haven, CT, USA
  • 3 School of Public Health and Social Work, Queensland University of Technology, Brisbane, QLD, Australia
  • 4 Nuffield College, University of Oxford, Oxford, UK
  • 5 Health Economics Research Centre, Nuffield Department of Population Health, University of Oxford, Oxford, UK. Philip.Clarke@ndph.ox.ac.uk
Pharmacoecon Open, 2020 Dec;4(4):557-561.
PMID: 32880878 DOI: 10.1007/s41669-020-00228-5

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications